# AdaptiveML — Cross-Phase Quality Audit: Phases 1 through 5

> **Document Status**: Complete Baseline Deliverable  
> **Document Identifier**: `DOC-AUD-001`  
> **Last Updated**: 2026-11-01  
> **Audited Phases**: Phase 1 (Market), Phase 2 (Novelty), Phase 3 (Legal/IP), Phase 4 (Literature), Phase 5 (Gaps)

---

## 1. Cross-Phase Coherence & Verification Checklist

This audit verifies strict alignment, traceability, and epistemic consistency across all completed research deliverables:

| Audit Check Item | Phase 1 Source | Phases 2–5 Implementation & Verification | Audit Result | Notes |
| :--- | :--- | :--- | :---: | :--- |
| **1. Market Problems vs. Research Questions** | PRB-RLA-001 (Minority pruning), PRB-ULC-001 (Drift-noise collision), PRB-RAO-001 (CPU RAM bloat) | Formulated as formal research questions (RQ-1, RQ-2, RQ-3) with falsifiable hypotheses ($H_1$) and null hypotheses ($H_0$) in Phase 5. | **PASSED** | Direct 1:1 problem-to-hypothesis mapping. |
| **2. Competitor Analysis vs. Prior Art** | River, Cleanlab, Avalanche, bitsandbytes, imbalanced-learn | Fully audited in Phase 2 with deep source-code inspection (`EXISTING_IMPLEMENTATION_ANALYSIS.md`). | **PASSED** | Claims separated from code reality. |
| **3. Novelty Claim Integrity** | Opportunity Matrix (Phase 1) | Re-classified into Established Art, DX Improvement, Adaptation, and Potential Research Contribution in Phase 2. Zero ungrounded novelty claims. | **PASSED** | Strict compliance with Governance Rule 3. |
| **4. Legal / IP Compatibility** | Minimal dependencies, proposed Apache-2.0 | Formally analyzed in Phase 3. Cleanlab AGPL-3.0 copyleft quarantined; Datadog "Adaptive ML" trademark conflict identified and mitigated via provisional codename and `aml-core` fallback. | **PASSED** | No licensing or trademark contradictions. |
| **5. Literature Review vs. Research Gaps** | 20 foundational citations (1951–2024) | Phase 4 dossiers (ALA, RLA, RAO) and ULC synthesis directly substantiate Gaps 01 through 06 in Phase 5. | **PASSED** | Gaps grounded in peer-reviewed failure modes. |
| **6. Evidence & Traceability** | Research Evidence Register | All claims cross-referenced with DOIs, patent publication numbers, and repository URLs across all phase registers. | **PASSED** | Complete traceability. |
| **7. Scientific Uncertainty Disclosed** | Success Criteria targets vs. achieved results | All proposed algorithmic improvements explicitly categorized as research hypotheses pending Phase 12 validation. | **PASSED** | No premature victory claims. |
| **8. Roadmap Preservation** | Master 22-phase roadmap (Phases 0–21) | Preserved exactly without merging, skipping, or shortening. | **PASSED** | Master roadmap intact. |
| **9. Zero Code Execution Boundary** | Foundational Scope restriction | Zero algorithmic Python source code written in Phases 2–5. | **PASSED** | Clean boundary preserved. |
| **10. Pillar Modularity Mandate** | Product Specification & Charter | ALA, RLA, and RAO remain 100% independent. ULC is strictly an optional coordinator. | **PASSED** | Decoupling maintained. |

---

## 2. Audit Conclusion

The cross-phase audit confirms that **Phases 1, 2, 3, 4, and 5 form an unassailable, internally consistent, scientifically rigorous research foundation**. The project is fully prepared to enter Phase 6 (Mathematical & Algorithm Design) upon owner sign-off.
